1. Home
  2. GKOS vs WTM Comparison

GKOS vs WTM Comparison

Compare GKOS & WTM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • GKOS
  • WTM
  • Stock Information
  • Founded
  • GKOS 1998
  • WTM 1980
  • Country
  • GKOS United States
  • WTM Bermuda
  • Employees
  • GKOS N/A
  • WTM N/A
  • Industry
  • GKOS Medical/Dental Instruments
  • WTM Property-Casualty Insurers
  • Sector
  • GKOS Health Care
  • WTM Finance
  • Exchange
  • GKOS Nasdaq
  • WTM Nasdaq
  • Market Cap
  • GKOS 5.1B
  • WTM 4.7B
  • IPO Year
  • GKOS 2015
  • WTM N/A
  • Fundamental
  • Price
  • GKOS $94.31
  • WTM $1,785.28
  • Analyst Decision
  • GKOS Strong Buy
  • WTM
  • Analyst Count
  • GKOS 13
  • WTM 0
  • Target Price
  • GKOS $135.15
  • WTM N/A
  • AVG Volume (30 Days)
  • GKOS 914.5K
  • WTM 15.8K
  • Earning Date
  • GKOS 04-30-2025
  • WTM 05-07-2025
  • Dividend Yield
  • GKOS N/A
  • WTM 0.06%
  • EPS Growth
  • GKOS N/A
  • WTM N/A
  • EPS
  • GKOS N/A
  • WTM 10.73
  • Revenue
  • GKOS $404,523,000.00
  • WTM $2,284,800,000.00
  • Revenue This Year
  • GKOS $27.89
  • WTM N/A
  • Revenue Next Year
  • GKOS $27.57
  • WTM N/A
  • P/E Ratio
  • GKOS N/A
  • WTM $166.41
  • Revenue Growth
  • GKOS 23.92
  • WTM 0.12
  • 52 Week Low
  • GKOS $77.10
  • WTM $1,666.22
  • 52 Week High
  • GKOS $163.71
  • WTM $2,023.00
  • Technical
  • Relative Strength Index (RSI)
  • GKOS 50.08
  • WTM 48.34
  • Support Level
  • GKOS $93.52
  • WTM $1,774.24
  • Resistance Level
  • GKOS $101.57
  • WTM $1,807.29
  • Average True Range (ATR)
  • GKOS 3.33
  • WTM 20.20
  • MACD
  • GKOS 0.40
  • WTM -1.58
  • Stochastic Oscillator
  • GKOS 42.24
  • WTM 30.94

About GKOS Glaukos Corporation

Glaukos Corp is an ophthalmic pharmaceutical and medical technology company focused on developing novel, dropless therapies and commercializing associated products for the treatment of glaucoma, corneal disorders, and retinal diseases. It has commenced commercialization activities for iDose TR, a first-of-its-kind, long-duration, intracameral procedural pharmaceutical implant designed to continuously deliver glaucoma drug therapy inside the eye for extended periods of time. The company also offer commercially a proprietary bio-activated pharmaceutical therapy for the treatment of a rare corneal disorder, keratoconus. It has three primary commercialized micro-scale surgical device products designed to treat glaucoma: the iStent, the iStent inject W, and the iStent infinite.

About WTM White Mountains Insurance Group Ltd.

White Mountains Insurance Group Ltd is engaged in the business of making opportunistic and value-oriented acquisitions of businesses and assets in the insurance, financial services, and related sectors, operating these businesses and assets through its subsidiaries and, if and when attractive exit valuations become available, disposing of these businesses and assets. The company conducts its business in five areas: property and casualty insurance and reinsurance, municipal bond reinsurance, capital solutions for asset and wealth management firms, property and casualty insurance distribution, and other operations.

Share on Social Networks: